| Part B: Supplementary Information Sheet (SIS) |
|
FR Recognition List Number
|
056
|
Date of Entry 06/07/2021
|
|
FR Recognition Number
|
2-290
|
| Standard | |
ISO TS 37137-1 First edition 2021-03
Biological evaluation of absorbable medical devices - Part 1: General requirements. |
|
Scope/Abstract| This document specifies the requirements for the evaluation of absorbable medical devices during a biological risk assessment based on ISO 10993-1, including a clarification of the terms "absorb", "degrade" and other related terms (see Annex A). |
|
Extent of Recognition
| Partial recognition. The following part(s) of the standard is (are) not recognized: |
| Reference to ISO 10993-1:2018, Annex A in Clause 8.2 a) and Clause 8.11. |
|
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.
This standard is recognized in part because:
Reference to ISO 10993-1:2018, Annex A in Clause 8.2 a) and Clause 8.11 are in conflict with an existing published final guidance, see Attachment A, Table A1 of the guidance listed below. |
|
Public Law, CFR Citation(s) and Procode(s)*
| 21 CFR 58 Good Laboratory Practice for Nonclinical Laboratory Studies |
|
Relevant FDA Guidance and/or Supportive Publications*
Guidance for Industry and Food and Drug Administration Staff: Use of International Standard ISO 10993-1, "Biological evaluation of medical devices--Part 1: Evaluation and testing within a risk management process", Issued September 2023.
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
| FDA Technical Contacts
|
| Standards Development Organization
|
| FDA Specialty Task Group (STG)
|
| *These are provided as examples and others may be applicable. |
